@FierceBiotech: Biotech building boom restricted to top "micro" hot spots. News | Follow @FierceBiotech
@JohnCFierce: Radius Health has closed a $27M tranche of its $91M financing round. | Follow @JohnCFierce
@RyanMFierce: Otsuka filed NDA for once-monthly version of Abilify, Alkermes ($ALKS) has rival drug in its pipeline. Report | Follow@RyanMFierce
@MaureenFierce: 2011 Fierce 15 winner Selecta Biosciences starts Phase I trial of synthetic nano-vaccine for smoking. Item | Follow@MaureenFierce
> Alex Barkas, the managing director at Prospect Venture Partners, has died. He was 64. Story
> The Malaysian Biotechnology Corporation has put together a $100 million venture fund for the country. Report
> The UK's GW Pharma plans to wrap late-stage testing of its cannabis-based Sativex for cancer pain by late 2013. An approval could help push European sales of the drug, approved for MS, to more than $250 million, according to analysts. Story
> India's Transgene Biotek has moved its recombinant human erythropoietin technology to Germany's TSS Export for $5 million. Story
> Proximagen and Altacor have struck a collaboration deal on a glaucoma program. Story
> Belgium's Galapagos NV says its JAK1 inhibitor, GLPG0634, achieved the primary endpoint of significant improvement in the signs and symptoms of rheumatoid arthritis in a Phase II study. Release
Pharma News
@FiercePharma: Merck criminal plea on Vioxx misbranding: DoJ says $MRK promoted for RA three yrs before FDA approved for that use.Release | Follow @FiercePharma
> EMA pulls cancer meds made by troubled CMO. Report
Vaccine News
> Study: Vaccine developers should target deadliest cancers. Article
> Selecta starts trial of synthetic nano-vaccine for smoking. News
> Combo vaccines may cost doctors money. Report
Drug Delivery News
> Will third time be the charm for Transcept's sleep drug? Article
> Drug coupled with peptide delivers targeted tumor treatment. Story
> FDA accepts Otsuka's app for long-lasting Abilify. Report
> Drug coupled with peptide delivers targeted tumor treatment. News
> Drug delivery may be possible through new polymer bathed in infrared light. Report
Medical Device News
> Flexuspine adds $2.1M to Series B. News
> Boston Scientific gets FDA nod for heart stent. More
> Sphere gets regulatory OK for manufacturing products in U.K. facility. Item
And Finally...Investigators at the NYU School of Medicine say they've found a potential Achilles' Heel for bacteria, opening up a promising pathway for developers of antibiotics. Release